BLFS Oct 2024 17.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:05PM EDT. Market open.
| Previous close | 2.9000 |
| Open | 2.9000 |
| Bid | 4.6000 |
| Ask | 7.9000 |
| Strike | 17.50 |
| Expiry date | 2024-10-18 |
| Day's range | 2.9000 - 2.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 26 |
ZacksBioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
PR NewswireBioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced the introduction of the CryoCase, an addition to its CellSeal product line.
GuruFocus.comInsider Sale: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...
On May 15, 2024, Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc (NASDAQ:BLFS), executed a sale of 10,000 shares of the company.
© 2024 Yahoo. All rights reserved.